National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.
------------------------------------------------------------
November 20, 2002
INTERNATIONAL IMMUNIZATION NEWS
"S. Africa in Drive for HIV Vaccine"
Financial Times (www.ft.com) (11/20/02) P. 5; Jenkins, Patrick
The South African AIDS Vaccine Initiative (SAAVI) recently secured a low-cost deal with the British scientific firm Cobra Biomanufacturing to supply the DNA that S.A. scientists need for the development of a revolutionary HIV vaccine. Human trials of the vaccine are scheduled for 2004. According to SAAVI director Tim Tucker, "It is our hope that we will find this candidate HIV vaccine effective in inducing a virorous immune response and eventually having a possible effect on the HIV pandemic." The SAAVI research, a component of a program coordinated by the South African Medical Research Council, is the only "homegrown" vaccine initiative in the world, although there are several others underway, including programs headed by drug giants GlaxoSmithKline and Merck.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.